Ann Oncol -- Annals of Oncology Advance Access

Annals of Oncology Advance Access

Annals of Oncology Advance Access articles are papers that have been copyedited and typeset but not yet paginated for inclusion in an issue of the journal. More information, including how to cite Advance Access papers, can be found on the Advance Access page.

Advance Access Articles By Date [View by Category]

To see an article, click its [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

17 November 2009

letter to the editor: D. Tassinari, F. Drudi, L. Lazzari-Agli, P. Tombesi, and S. Sartori
Second-line treatments of advanced non-small-cell lung cancer: new evidence for clinical practice
Annals of Oncology Advance Access published on November 17, 2009.
doi:10.1093/annonc/mdp538
[Extract] [Full Text] [PDF] [Request Permissions]

Abstract original article: A. Bari, L. Marcheselli, S. Sacchi, R. Marcheselli, S. Pozzi, P. Ferri, E. Balleari, P. Musto, S. Neri, M. A. Aloe Spiriti, and M. C. Cox
Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story
Annals of Oncology Advance Access published on November 17, 2009.
doi:10.1093/annonc/mdp531
[Abstract] [Full Text] [PDF] [Request Permissions]

16 November 2009

Abstract original article: M. Khasraw, N. Pavlakis, S. McCowatt, C. Underhill, S. Begbie, P. de Souza, A. Boyce, F. Parnis, V. Lim, R. Harvie, and G. Marx
Multicentre phase I/II study of PI-88, a heparanase inhibitor in combination with docetaxel in patients with metastatic castrate-resistant prostate cancer
Annals of Oncology Advance Access published on November 16, 2009.
doi:10.1093/annonc/mdp524
[Abstract] [Full Text] [PDF] [Request Permissions]

13 November 2009

Abstract original article: H. Ghesquières, C. Ferlay, C. Sebban, D. Perol, A. Bosly, O. Casasnovas, O. Reman, B. Coiffier, H. Tilly, P. Morel, E. Van den Neste, P. Colin, C. Haioun, P. Biron, and J.-Y. Blay
Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA)
Annals of Oncology Advance Access originally published on November 13, 2009. This version published November 18, 2009.
doi:10.1093/annonc/mdp529
[Abstract] [Full Text] [PDF] [Request Permissions]

letter to the editor: B. Glimelius, K.L. Spindler, J.-E. Frödin, Å. Berglund, P. Byström, C. Qvortrup, A. Jakobsen, and P. Pfeiffer
Long-term follow-up of chemonaive patients with asymptomatic metastatic colorectal cancer treated with enzastaurin in a window of opportunity phase II study
Annals of Oncology Advance Access published on November 13, 2009.
doi:10.1093/annonc/mdp526
[Extract] [Full Text] [PDF] [Request Permissions]

Abstract original article: A. Camerini, C. Valsuani, F. Mazzoni, O. Siclari, C. Puccetti, S. Donati, M. Rondini, G. Tartarelli, P. Puccinelli, F. Di Costanzo, and D. Amoroso
Phase II trial of single-agent oral vinorelbine in elderly ( $≥$ 70 years) patients with advanced non-small-cell lung cancer and poor performance status
Annals of Oncology Advance Access published on November 13, 2009.
doi:10.1093/annonc/mdp525
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: U. Petrausch, P. Samaras, P. Veit-Haibach, A. Tschopp, J. D. Soyka, A. Knuth, T. F. Hany, A. Mischo, C. Renner, and N. G. Schaefer
Hodgkin’s lymphoma in remission after first-line therapy: which patients need FDG–PET/CT for follow-up?
Annals of Oncology Advance Access published on November 13, 2009.
doi:10.1093/annonc/mdp519
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: C. E. Paiva, S. A. Drigo, F. E. Rosa, F. A. Moraes Neto, J. R. F. Caldeira, F. A. Soares, M. A. C. Domingues, and S. R. Rogatto
Absence of transforming growth factor-β type II receptor is associated with poorer prognosis in HER2-negative breast tumours
Annals of Oncology Advance Access published on November 13, 2009.
doi:10.1093/annonc/mdp518
[Abstract] [Full Text] [PDF] [Supplementary Data] [Request Permissions]

Abstract original article: P. Xie, J.-B. Yue, Z. Fu, R. Feng, and J.-M. Yu
Prognostic value of ¹⁸F-FDG PET/CT before and after radiotherapy for locally advanced nasopharyngeal carcinoma
Annals of Oncology Advance Access published on November 13, 2009.
doi:10.1093/annonc/mdp430
[Abstract] [Full Text] [PDF] [Request Permissions]

11 November 2009

Abstract original article
S. Pecorelli, I. Ray-Coquard, O. Tredan, N. Colombo, G. Parma, G. Tisi, D. Katsaròs, C. Lhommé, A. A. Lissoni, J. B. Vermorken, A. du Bois, A. Poveda, L. Frigerio, P. Barbieri, P. Carminati, S. Brienza, and J. P. Guastalla
Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes
Annals of Oncology Advance Access published on November 11, 2009.
doi:10.1093/annonc/mdp514
[Abstract] [Full Text] [PDF] OPEN ACCESS ARTICLE

Abstract original article: D. Mavroudis, P. Papakotoulas, A. Ardavanis, K. Syrigos, S. Kakolyris, N. Ziras, C. Kouroussis, N. Malamos, A. Polyzos, C. Christophyllakis, N. Kentepozidis, V. Georgoulias, and on behalf of the Breast Cancer Investigators of the Hellenic Oncology Research Group
Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first-line treatment in women with advanced breast cancer
Annals of Oncology Advance Access published on November 11, 2009.
doi:10.1093/annonc/mdp498
[Abstract] [Full Text] [PDF] [Request Permissions]

10 November 2009

letter to the editor: J. B. Aragon-Ching and W. L. Dahut
About tyrosine kinase inhibitors (TKIs) in prostate cancer: where do we go from here?
Annals of Oncology Advance Access published on November 10, 2009.
doi:10.1093/annonc/mdp467
[Extract] [Full Text] [PDF] [Request Permissions]

9 November 2009

Abstract review: O. Gluz, C. Liedtke, N. Gottschalk, L. Pusztai, U. Nitz, and N. Harbeck
Triple-negative breast cancer—current status and future directions
Annals of Oncology Advance Access published on November 9, 2009.
doi:10.1093/annonc/mdp492
[Abstract] [Full Text] [PDF] [Request Permissions]

letter to the editor: S. J. Proctor, A. L. Lennard, G. H. Jackson, G. L. Jones, J. Lewis, J. Wilkinson, J. White, M. Sieniawski, P. McKay, D. Culligan, and H. H. Lucraft
The role of an all-oral chemotherapy containing lomustine (CCNU) in advanced, progressive Hodgkin lymphoma: a patient-friendly palliative option which can result in long-term disease control
Annals of Oncology Advance Access published on November 9, 2009.
doi:10.1093/annonc/mdp527
[Extract] [Full Text] [PDF] [Request Permissions]

Abstract review: E. D. Saad, A. Katz, P. M. Hoff, and M. Buyse
Progression-free survival as surrogate and as true end point: insights from the breast and colorectal cancer literature
Annals of Oncology Advance Access published on November 9, 2009.
doi:10.1093/annonc/mdp523
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: H. Mocikova, P. Obrtlikova, B. Vackova, and M. Trneny
Positron emission tomography at the end of first-line therapy and during follow-up in patients with Hodgkin lymphoma: a retrospective study
Annals of Oncology Advance Access published on November 9, 2009.
doi:10.1093/annonc/mdp522
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: B. Glimelius, M. Lahn, S. Gawande, A. Cleverly, C. Darstein, L. Musib, Y. Liu, K. L. Spindler, J.-E. Frödin, Å. Berglund, P. Byström, C. Qvortrup, A. Jakobsen, and P. Pfeiffer
A window of opportunity phase II study of enzastaurin in chemonaive patients with asymptomatic metastatic colorectal cancer
Annals of Oncology Advance Access published on November 9, 2009.
doi:10.1093/annonc/mdp521
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: E. A. Perez, D. W. Hillman, T. Dentchev, N. A. Le-Lindqwister, L. H. Geeraerts, T. R. Fitch, H. Liu, D. L. Graham, S. P. Kahanic, H. M. Gross, T. A. Patel, F. M. Palmieri, and A. C. Dueck
North Central Cancer Treatment Group (NCCTG) N0432: phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer
Annals of Oncology Advance Access published on November 9, 2009.
doi:10.1093/annonc/mdp512
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: C. Sessa, D. Tosi, L. Viganò, J. Albanell, D. Hess, M. Maur, S. Cresta, A. Locatelli, R. Angst, F. Rojo, N. Coceani, V. M. Rivera, L. Berk, F. Haluska, and L. Gianni
Phase Ib study of weekly mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) with weekly paclitaxel
Annals of Oncology Advance Access published on November 9, 2009.
doi:10.1093/annonc/mdp504
[Abstract] [Full Text] [PDF] [Supplementary Data] [Request Permissions]

5 November 2009

Abstract original article: B. Zhou, M. Qie, Y. Wang, L. Yan, Z. Zhang, A. Liang, T. Wang, X. Wang, Y. Song, and L. Zhang
Relationship between NFKB1 –94 insertion/deletion ATTG polymorphism and susceptibility of cervical squamous cell carcinoma risk
Annals of Oncology Advance Access published on November 5, 2009.
doi:10.1093/annonc/mdp507
[Abstract] [Full Text] [PDF] [Request Permissions]

letter to the editor: X. Bertagna, P. Boudou-Rouquette, J. Alexandre, O. Soubrane, and F. Goldwasser
Reply to Bone morphogenetic proteins and zoledronic acid
Annals of Oncology Advance Access published on November 5, 2009.
doi:10.1093/annonc/mdp503
[Extract] [Full Text] [PDF] [Request Permissions]

letter to the editor: D. Santini, S. Galluzzo, B. Vincenzi, A. Zoccoli, E. Ferraro, C. Lippi, V. Altomare, G. Tonini, and F. Bertoldo
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients
Annals of Oncology Advance Access published on November 5, 2009.
doi:10.1093/annonc/mdp497
[Extract] [Full Text] [PDF] [Request Permissions]

Abstract original article: L. J. Wirth, A. M. Allen, M. R. Posner, R. I. Haddad, Y. Li, J. R. Clark, P. M. Busse, A. W. Chan, L. A. Goguen, C. M. Norris, D. J. Annino, and R. B. Tishler
Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck
Annals of Oncology Advance Access published on November 5, 2009.
doi:10.1093/annonc/mdp477
[Abstract] [Full Text] [PDF] [Request Permissions]

4 November 2009

Abstract original article: S. M. Radaideh, V. C. Cook, K. A. Kesler, and L. H. Einhorn
Outcome following resection for patients with primary mediastinal nonseminomatous germ-cell tumors and rising serum tumor markers post-chemotherapy
Annals of Oncology Advance Access published on November 4, 2009.
doi:10.1093/annonc/mdp516
[Abstract] [Full Text] [PDF] [Request Permissions]

letter to the editor: M. Kanai, S. Matsumoto, T. Nishimura, Y. Matsumura, E. Hatano, A. Mori, T. Masui, Y. Kawaguchi, E. Nakamura, S. Tada, T. Kitano, H. Ishiguro, K. Yanagihara, and T. Chiba
Premedication with 20 mg dexamethasone effectively prevents relapse of extensive skin rash associated with gemcitabine monotherapy
Annals of Oncology Advance Access published on November 4, 2009.
doi:10.1093/annonc/mdp513
[Extract] [Full Text] [PDF] [Request Permissions]

Abstract original article: A. du Bois, J. Huober, P. Stopfer, J. Pfisterer, P. Wimberger, S. Loibl, V. L. Reichardt, and P. Harter
A phase I open-label dose-escalation study of oral BIBF 1120 combined with standard paclitaxel and carboplatin in patients with advanced gynecological malignancies
Annals of Oncology Advance Access published on November 4, 2009.
doi:10.1093/annonc/mdp506
[Abstract] [Full Text] [PDF] [Supplementary Data] [supplementary figures] [Request Permissions]

Abstract original article: P. Picci, M. Mercuri, S. Ferrari, M. Alberghini, A. Briccoli, C. Ferrari, E. Pignotti, and G. Bacci
Survival in high-grade osteosarcoma: improvement over 21 years at a single institution
Annals of Oncology Advance Access published on November 4, 2009.
doi:10.1093/annonc/mdp502
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: M. Kusters, V. Valentini, F. A. Calvo, R. Krempien, G. A. Nieuwenhuijzen, H. Martijn, G. B. Doglietto, E. del Valle, F. Roeder, M. W. Buchler, C. J. H. van de Velde, and H. J. T. Rutten
Results of European pooled analysis of IORT-containing multimodality treatment for locally advanced rectal cancer: adjuvant chemotherapy prevents local recurrence rather than distant metastases
Annals of Oncology Advance Access published on November 4, 2009.
doi:10.1093/annonc/mdp501
[Abstract] [Full Text] [PDF] [Request Permissions]

editorial: M. Mandala, A. Falanga, and R. Labianca
Video meliora proboque sed deteriora sequor: the case of thromboprophylaxis in hospitalized cancer patients
Annals of Oncology Advance Access published on November 4, 2009.
doi:10.1093/annonc/mdp500
[Extract] [Full Text] [PDF] [Request Permissions]

Abstract original article: S. Jin, Q. Y. Zhang, X. M. Kang, J. X. Wang, and W. H. Zhao
Daidzein induces MCF-7 breast cancer cell apoptosis via the mitochondrial pathway
Annals of Oncology Advance Access published on November 4, 2009.
doi:10.1093/annonc/mdp499
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: C. Larbouret, B. Robert, C. Bascoul-Mollevi, F. Penault-Llorca, A. Ho-Pun-Cheung, S. Morisseau, I. Navarro-Teulon, J.-P. Mach, A. Pèlegrin, and D. Azria
Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts
Annals of Oncology Advance Access published on November 4, 2009.
doi:10.1093/annonc/mdp496
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article
M. Laé, J. Couturier, S. Oudard, F. Radvanyi, P. Beuzeboc, and A. Vieillefond
Assessing HER2 gene amplification as a potential target for therapy in invasive urothelial bladder cancer with a standardized methodology: results in 1005 patients
Annals of Oncology Advance Access published on November 4, 2009.
doi:10.1093/annonc/mdp488
[Abstract] [Full Text] [PDF] OPEN ACCESS ARTICLE

Abstract original article: C. Fernández de Larrea, C. Martínez, A. Gaya, A. López-Guillermo, M. Rovira, F. Fernández-Avilés, M. Lozano, F. Bosch, J. Esteve, B. Nomdedeu, E. Montserrat, and E. Carreras
Salvage chemotherapy with alternating MINE–ESHAP regimen in relapsed or refractory Hodgkin's lymphoma followed by autologous stem-cell transplantation
Annals of Oncology Advance Access published on November 4, 2009.
doi:10.1093/annonc/mdp487
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: A. Holmqvist, J. Gao, G. Adell, J. Carstensen, and X.-F. Sun
The location of lymphangiogenesis is an independent prognostic factor in rectal cancers with or without preoperative radiotherapy
Annals of Oncology Advance Access published on November 4, 2009.
doi:10.1093/annonc/mdp486
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: R. Seki, K. Ohshima, T. Fujisaki, N. Uike, F. Kawano, H. Gondo, S. Makino, T. Eto, Y. Moriuchi, F. Taguchi, T. Kamimura, H. Tsuda, K. Shimoda, and T. Okamura
Prognostic significance of S-phase kinase-associated protein 2 and p27^kip1 in patients with diffuse large B-cell lymphoma: effects of rituximab
Annals of Oncology Advance Access published on November 4, 2009.
doi:10.1093/annonc/mdp481
[Abstract] [Full Text] [PDF] [Request Permissions]

letter to the editor: E. N. M. Overkleeft, R. Goldschmeding, F. van Reekum, E. E. Voest, and H. M. W. Verheul
Nephrotic syndrome caused by the angiogenesis inhibitor sorafenib
Annals of Oncology Advance Access published on November 4, 2009.
doi:10.1093/annonc/mdp472
[Extract] [Full Text] [PDF] [Request Permissions]

letter to the editor: L. Fornaro, E. Vasile, G. Masi, F. Loupakis, S. Caponi, L. Ginocchi, and A. Falcone
Capecitabine after gastrectomy for advanced gastric cancer: have we got the patient right?
Annals of Oncology Advance Access published on November 4, 2009.
doi:10.1093/annonc/mdp469
[Extract] [Full Text] [PDF] [Request Permissions]

Abstract original article: R. Thiam, L. S. Fournier, L. Trinquart, J. Medioni, G. Chatellier, D. Balvay, B. Escudier, C. Dromain, C. A. Cuenod, and S. Oudard
Optimizing the size variation threshold for the CT evaluation of response in metastatic renal cell carcinoma treated with sunitinib
Annals of Oncology Advance Access published on November 4, 2009.
doi:10.1093/annonc/mdp466
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: G. D. Batty, F. Barzi, M. Woodward, K. Jamrozik, J. Woo, H. C. Kim, H. Ueshima, R. R. Huxley, and for the Asia Pacific Cohort Studies Collaboration
Adult height and cancer mortality in Asia: the Asia Pacific Cohort Studies Collaboration
Annals of Oncology Advance Access published on November 4, 2009.
doi:10.1093/annonc/mdp363
[Abstract] [Full Text] [PDF] [Request Permissions]

3 November 2009

letter to the editor: O. Mir, P. Berveiller, F. Goffinet, J.-M. Treluyer, R. Serreau, F. Goldwasser, and R. Rouzier
Taxanes for breast cancer during pregnancy: a systematic review
Annals of Oncology Advance Access published on November 3, 2009.
doi:10.1093/annonc/mdp517
[Extract] [Full Text] [PDF] [Request Permissions]

Abstract review: S. Singer, J. Das-Munshi, and E. Brähler
Prevalence of mental health conditions in cancer patients in acute care—a meta-analysis
Annals of Oncology Advance Access published on November 3, 2009.
doi:10.1093/annonc/mdp515
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: S. Park, J. Koo, H. S. Park, J.-H. Kim, S.-Y. Choi, J. H. Lee, B.-W. Park, and K. S. Lee
Expression of androgen receptors in primary breast cancer
Annals of Oncology Advance Access published on November 3, 2009.
doi:10.1093/annonc/mdp510
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: R. K. Ramanathan, M. L. Rothenberg, A. de Gramont, C. Tournigand, R. M. Goldberg, S. Gupta, and T. André
Incidence and evolution of oxaliplatin-induced peripheral sensory neuropathy in diabetic patients with colorectal cancer: a pooled analysis of three phase III studies
Annals of Oncology Advance Access published on November 3, 2009.
doi:10.1093/annonc/mdp509
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: P. L. Zinzani, F. Venturini, V. Stefoni, M. Fina, C. Pellegrini, E. Derenzini, L. Gandolfi, A. Broccoli, L. Argnani, F. Quirini, S. Pileri, and M. Baccarani
Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome
Annals of Oncology Advance Access published on November 3, 2009.
doi:10.1093/annonc/mdp508
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: M.-K. Song, J.-S. Chung, Y.-M. Seol, S.-G. Kim, H.-J. Shin, Y.-J. Choi, G.-J. Cho, and D.-H. Shin
Influence of low absolute lymphocyte count of patients with nongerminal center type diffuse large B-cell lymphoma with R-CHOP therapy
Annals of Oncology Advance Access published on November 3, 2009.
doi:10.1093/annonc/mdp505
[Abstract] [Full Text] [PDF] [Request Permissions]

2 November 2009

letter to the editor: B. Martin-Castillo, J. Dorca, A. Vazquez-Martin, C. Oliveras-Ferraros, E. Lopez-Bonet, M. Garcia, S. del Barco, and J. A. Menendez
Incorporating the antidiabetic drug metformin in HER2-positive breast cancer treated with neo-adjuvant chemotherapy and trastuzumab: an ongoing clinical–translational research experience at the Catalan Institute of Oncology
Annals of Oncology Advance Access published on November 2, 2009.
doi:10.1093/annonc/mdp494
[Extract] [Full Text] [PDF] [Request Permissions]

Abstract original article: D. Ennishi, H. Asai, Y. Maeda, K. Shinagawa, K. Ikeda, M. Yokoyama, Y. Terui, K. Takeuchi, T. Yoshino, K. Matsuo, K. Hatake, and M. Tanimoto
Statin-independent prognosis of patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy
Annals of Oncology Advance Access published on November 2, 2009.
doi:10.1093/annonc/mdp490
[Abstract] [Full Text] [PDF] [Request Permissions]

30 October 2009

Abstract original article: P. Schmid, P. Kiewe, K. Possinger, A. Korfel, S. Lindemann, M. Giurescu, S. Reif, H. Wiesinger, E. Thiel, and D. Kühnhardt
Phase I study of the novel, fully synthetic epothilone sagopilone (ZK-EPO) in patients with solid tumors
Annals of Oncology Advance Access published on October 30, 2009.
doi:10.1093/annonc/mdp491
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: N. Penel, A. Italiano, N. Isambert, E. Bompas, G. Bousquet, F. Duffaud, and on behalf of the French Sarcoma Group (Groupe Sarcome Français/Groupe d'Etude des Tumeurs Osseuses)
Factors affecting the outcome of patients with metastatic leiomyosarcoma treated with doxorubicin-containing chemotherapy
Annals of Oncology Advance Access published on October 30, 2009.
doi:10.1093/annonc/mdp485
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: Y. L. Kasamon, R. J. Jones, R. A. Brodsky, E. J. Fuchs, W. Matsui, L. Luznik, J. D. Powell, A. L. Blackford, A. Goodrich, C. D. Gocke, R. A. Abrams, R. F. Ambinder, and I. W. Flinn
Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma
Annals of Oncology Advance Access published on October 30, 2009.
doi:10.1093/annonc/mdp484
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: G. Palmieri, G. Merola, P. Federico, L. Petillo, M. Marino, M. Lalle, M. Milella, A. Ceribelli, L. Montella, C. Merola, S. Del Prete, M. Bergaglio, S. De Placido, and G. Di Lorenzo
Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs)
Annals of Oncology Advance Access published on October 30, 2009.
doi:10.1093/annonc/mdp483
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: L. N. van Steenbergen, H. J. T. Rutten, G. J. Creemers, J. F. M. Pruijt, J. W. W. Coebergh, and V. E. P. P. Lemmens
Large age and hospital-dependent variation in administration of adjuvant chemotherapy for stage III colon cancer in southern Netherlands
Annals of Oncology Advance Access published on October 30, 2009.
doi:10.1093/annonc/mdp482
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article
B. Oh, P. Butow, B. Mullan, S. Clarke, P. Beale, N. Pavlakis, E. Kothe, L. Lam, and D. Rosenthal
Impact of Medical Qigong on quality of life, fatigue, mood and inflammation in cancer patients: a randomized controlled trial
Annals of Oncology Advance Access published on October 30, 2009.
doi:10.1093/annonc/mdp479
[Abstract] [Full Text] [PDF] OPEN ACCESS ARTICLE

Abstract original article: A. P. B. Batschauer, C. P. Figueiredo, E. C. Bueno, M. A. Ribeiro, L. M. S. Dusse, A. P. Fernandes, K. B. Gomes, and M. G. Carvalho
D-dimer as a possible prognostic marker of operable hormone receptor-negative breast cancer
Annals of Oncology Advance Access published on October 30, 2009.
doi:10.1093/annonc/mdp474
[Abstract] [Full Text] [PDF] [Request Permissions]

29 October 2009

letter to the editor: J. Edeline, B. Laguerre, Y. Rolland, and J.-J. Patard
Aortic dissection in a patient treated by sunitinib for metastatic renal cell carcinoma
Annals of Oncology Advance Access published on October 29, 2009.
doi:10.1093/annonc/mdp480
[Extract] [Full Text] [PDF] [Request Permissions]

Abstract original article: P. A. Tang, G. R. Pond, and E. X. Chen
Influence of an independent review committee on assessment of response rate and progression-free survival in phase III clinical trials
Annals of Oncology Advance Access published on October 29, 2009.
doi:10.1093/annonc/mdp478
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: C. Kollmannsberger, C. Moore, K. N. Chi, N. Murray, S. Daneshmand, M. Gleave, B. Hayes-Lattin, and C.R. Nichols
Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacy
Annals of Oncology Advance Access published on October 29, 2009.
doi:10.1093/annonc/mdp473
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: B. Banelli, I. Casciano, A. Di Vinci, B. Gatteschi, A. Levaggi, F. Carli, C. Bighin, S. Salvi, G. Allemanni, P. Ghiorzo, P. Pronzato, M. Venturini, M. Romani, and L. Del Mastro
Pathological and molecular characteristics distinguishing contralateral metastatic from new primary breast cancer
Annals of Oncology Advance Access published on October 29, 2009.
doi:10.1093/annonc/mdp470
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: W. Koizumi, H. Takiuchi, Y. Yamada, N. Boku, N. Fuse, K. Muro, Y. Komatsu, and A. Tsuburaya
Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study)
Annals of Oncology Advance Access published on October 29, 2009.
doi:10.1093/annonc/mdp464
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: J. W. Sweetenham, B. Goldman, M. L. LeBlanc, J. R. Cook, R. R. Tubbs, O. W. Press, D. G. Maloney, R. I. Fisher, L. M. Rimsza, R. M. Braziel, and E. D. Hsi
Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study
Annals of Oncology Advance Access published on October 29, 2009.
doi:10.1093/annonc/mdp460
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: G. Lahat, D. Tuvin, C. Wei, W. L. Wang, R. E. Pollock, D. A. Anaya, B. N. Bekele, L. Corely, A. J. Lazar, P. W. Pisters, and D. Lev
Molecular prognosticators of complex karyotype soft tissue sarcoma outcome: a tissue microarray-based study
Annals of Oncology Advance Access published on October 29, 2009.
doi:10.1093/annonc/mdp459
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: P. K. H. Morrow, J. J. Tarrand, S. H. Taylor, S.-W. C. Kau, R. L. Theriault, G. N. Hortobagyi, K. R. Broglio, and K. M. Hahn
Effects of chronic hepatitis C infection on the treatment of breast cancer patients
Annals of Oncology Advance Access published on October 29, 2009.
doi:10.1093/annonc/mdp458
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: G. Masci, L. Di Tommaso, I. Del Prato, S. Orefice, A. Rubino, G. Gullo, M. Zuradelli, R. Sacco, M. Alloisio, M. Eboli, M. Incarbone, L. Giordano, M. Roncalli, and A. Santoro
Sinusal localization of nodal micrometastases is a prognostic factor in breast cancer
Annals of Oncology Advance Access originally published on October 29, 2009. This version published November 10, 2009.
doi:10.1093/annonc/mdp453
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: D. H. Kim, W. Xu, S. Kamel-Reid, X. Liu, C. W. Jung, S. Kim, and J. H. Lipton
Clinical relevance of vascular endothelial growth factor (VEGFA) and VEGF receptor (VEGFR2) gene polymorphism on the treatment outcome following imatinib therapy
Annals of Oncology Advance Access published on October 29, 2009.
doi:10.1093/annonc/mdp452
[Abstract] [Full Text] [PDF] [Supplementary Data] [Request Permissions]

Abstract original article: J. F. R. Robertson, G. G. Steger, P. Neven, S. Barni, F. Gieseking, F. Nolè, K. I. Pritchard, F. P. O'Malley, S. D. Simon, B. Kaufman, and L. Petruzelka
Activity of fulvestrant in HER2-overexpressing advanced breast cancer
Annals of Oncology Advance Access published on October 29, 2009.
doi:10.1093/annonc/mdp447
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: J. G. H. van Nes, C. Seynaeve, E. Maartense, R. M. H. Roumen, R. S. de Jong, L. V. A. M. Beex, W. M. Meershoek-Klein Kranenbarg, H. Putter, J. W. R. Nortier, C. J. H. van de Velde, and for the Cooperating investigators of the Dutch TEAM trial
Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial
Annals of Oncology Advance Access published on October 29, 2009.
doi:10.1093/annonc/mdp419
[Abstract] [Full Text] [PDF] [Request Permissions]

27 October 2009

Abstract original article: J. S. Park, H. K. Kim, Y. S. Choi, K. Kim, Y. M. Shim, J. Jo, W.-Y. Lee, H.-K. Chun, Y. S. Park, W. K. Kang, and J. Kim
Outcomes after repeated resection for recurrent pulmonary metastases from colorectal cancer
Annals of Oncology Advance Access published on October 27, 2009.
doi:10.1093/annonc/mdp475
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: J. Tol, M. Koopman, M. C. Miller, A. Tibbe, A. Cats, G. J. M. Creemers, A. H. Vos, I. D. Nagtegaal, L. W. M. M. Terstappen, and C. J. A. Punt
Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents
Annals of Oncology Advance Access published on October 27, 2009.
doi:10.1093/annonc/mdp463
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: E. Derenzini, M. P. Fina, V. Stefoni, C. Pellegrini, F. Venturini, A. Broccoli, L. Gandolfi, S. Pileri, S. Fanti, E. Lopci, P. Castellucci, C. Agostinelli, M. Baccarani, and P. L. Zinzani
MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients
Annals of Oncology Advance Access published on October 27, 2009.
doi:10.1093/annonc/mdp455
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: J. Doyen, A. Italiano, R. Largillier, J.-M. Ferrero, X. Fontana, and A. Thyss
Aromatase inhibition in male breast cancer patients: biological and clinical implications
Annals of Oncology Advance Access published on October 27, 2009.
doi:10.1093/annonc/mdp450
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: A. S. Strimpakos, D. Cunningham, C. Mikropoulos, I. Petkar, Y. Barbachano, and I. Chau
The impact of carcinoembryonic antigen flare in patients with advanced colorectal cancer receiving first-line chemotherapy
Annals of Oncology Advance Access published on October 27, 2009.
doi:10.1093/annonc/mdp449
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: D. Villa, J. M. Connors, T. N. Shenkier, R. D. Gascoyne, L. H. Sehn, and K. J. Savage
Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy
Annals of Oncology Advance Access published on October 27, 2009.
doi:10.1093/annonc/mdp432
[Abstract] [Full Text] [PDF] [Request Permissions]

25 October 2009

letter to the editor: C. Serrano, C. Suárez, J. Andreu, and J. Carles
Acute aortic dissection during sorafenib-containing therapy
Annals of Oncology Advance Access published on October 25, 2009.
doi:10.1093/annonc/mdp468
[Extract] [Full Text] [PDF] [Request Permissions]

Abstract original article: M. Paulli, L. Arcaini, M. Lucioni, E. Boveri, D. Capello, F. Passamonti, M. Merli, S. Rattotti, D. Rossi, R. Riboni, E. Berti, U. Magrini, R. Bruno, G. Gaidano, and M. Lazzarino
Subcutaneous ‘lipoma-like’ B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT
Annals of Oncology Advance Access published on October 25, 2009.
doi:10.1093/annonc/mdp454
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: S.J. Aitken, J.S. Thomas, S.P. Langdon, D.J. Harrison, and D. Faratian
Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases
Annals of Oncology Advance Access originally published on October 25, 2009. This version published November 3, 2009.
doi:10.1093/annonc/mdp427
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: J.-Y. Park, D.-Y. Kim, J.-H. Kim, Y.-M. Kim, Y.-T. Kim, and J.-H. Nam
Management of occult invasive cervical cancer found after simple hysterectomy
Annals of Oncology Advance Access published on October 25, 2009.
doi:10.1093/annonc/mdp426
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: C. Guethlin, H. Walach, J. Naumann, H.-H. Bartsch, and M. Rostock
Characteristics of cancer patients using homeopathy compared with those in conventional care: a cross-sectional study
Annals of Oncology Advance Access published on October 25, 2009.
doi:10.1093/annonc/mdp421
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: C. Wibmer, A. Leithner, N. Zielonke, M. Sperl, and R. Windhager
Increasing incidence rates of soft tissue sarcomas? A population-based epidemiologic study and literature review
Annals of Oncology Advance Access published on October 25, 2009.
doi:10.1093/annonc/mdp415
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: A. Guerrieri-Gonzaga, E. Botteri, M. Lazzeroni, N. Rotmensz, A. Goldhirsch, C. Varricchio, D. Serrano, M. Cazzaniga, F. Bassi, A. Luini, V. Bagnardi, G. Viale, S. Mora, G. Bollani, E. Albertazzi, B. Bonanni, and A. Decensi
Low-dose tamoxifen in the treatment of breast ductal intraepithelial neoplasia: results of a large observational study
Annals of Oncology Advance Access published on October 25, 2009.
doi:10.1093/annonc/mdp408
[Abstract] [Full Text] [PDF] [Request Permissions]

23 October 2009

Abstract original article: H. Jinno, M. Sakata, T. Hayashida, M. Takahashi, M. Mukai, T. Ikeda, and Y. Kitagawa
A phase II trial of capecitabine and docetaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide (FEC) as preoperative treatment in women with stage II/III breast cancer
Annals of Oncology Advance Access published on October 23, 2009.
doi:10.1093/annonc/mdp428
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: N. Steeghs, T. J. Rabelink, J. op ’t Roodt, E. Batman, F. H. M. Cluitmans, N. I. Weijl, E. de Koning, and H. Gelderblom
Reversibility of capillary density after discontinuation of bevacizumab treatment
Annals of Oncology Advance Access published on October 23, 2009.
doi:10.1093/annonc/mdp417
[Abstract] [Full Text] [PDF] [Request Permissions]

22 October 2009

Abstract original article: H.A. Azim, L. Santoro, R.G. Bociek, S. Gandini, R.A. Malek, and H.A. Azim Jr
High dose intensity doxorubicin in aggressive non-Hodgkin's lymphoma: a literature-based meta-analysis
Annals of Oncology Advance Access published on October 22, 2009.
doi:10.1093/annonc/mdp425
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: R. Suzuki, J. Suzumiya, M. Yamaguchi, S. Nakamura, J. Kameoka, H. Kojima, M. Abe, T. Kinoshita, T. Yoshino, K. Iwatsuki, Y. Kagami, T. Tsuzuki, M. Kurokawa, K. Ito, K. Kawa, K. Oshimi, and for The NK-cell Tumor Study Group
Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type
Annals of Oncology Advance Access published on October 22, 2009.
doi:10.1093/annonc/mdp418
[Abstract] [Full Text] [PDF] [Supplementary Data] [Request Permissions]

Abstract original article: M. van Waas, S. J. C. M. M. Neggers, R. Pieters, and M. M. van den Heuvel-Eibrink
Components of the metabolic syndrome in 500 adult long-term survivors of childhood cancer
Annals of Oncology Advance Access published on October 22, 2009.
doi:10.1093/annonc/mdp414
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: S. J. Kim, S. Y. Oh, J. Y. Hong, M. H. Chang, D. H. Lee, J. Huh, Y. H. Ko, Y. C. Ahn, H.-J. Kim, C. Suh, K. Kim, and W. S. Kim
When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type?
Annals of Oncology Advance Access published on October 22, 2009.
doi:10.1093/annonc/mdp412
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: C. Massard, J. Zonierek, M. Gross-Goupil, K. Fizazi, C. Szczylik, and B. Escudier
Incidence of brain metastases in renal cell carcinoma treated with sorafenib
Annals of Oncology Advance Access published on October 22, 2009.
doi:10.1093/annonc/mdp411
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: S. Luminari, M. Cesaretti, L. Marcheselli, I. Rashid, S. Madrigali, A. Maiorana, and M. Federico
Decreasing incidence of gastric MALT lymphomas in the era of anti-Helicobacter pylori interventions: results from a population-based study on extranodal marginal zone lymphomas
Annals of Oncology Advance Access published on October 22, 2009.
doi:10.1093/annonc/mdp402
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: F.-C. Bidard, C. Mathiot, S. Delaloge, E. Brain, S. Giachetti, P. de Cremoux, M. Marty, and J.-Y. Pierga
Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer
Annals of Oncology Advance Access published on October 22, 2009.
doi:10.1093/annonc/mdp391
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: C. H. Chung, J. Aulino, N. J. Muldowney, H. Hatakeyama, J. Baumann, B. Burkey, J. Netterville, R. Sinard, W. G. Yarbrough, A. J. Cmelak, R. J. Slebos, Y. Shyr, J. Parker, J. Gilbert, and B. A. Murphy
Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
Annals of Oncology Advance Access published on October 22, 2009.
doi:10.1093/annonc/mdp390
[Abstract] [Full Text] [PDF] [Supplementary Data] [Request Permissions]

Abstract original article: K.-L. G. Spindler, R. F. Andersen, L. H. Jensen, J. Ploen, and A. Jakobsen
EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer
Annals of Oncology Advance Access published on October 22, 2009.
doi:10.1093/annonc/mdp336
[Abstract] [Full Text] [PDF] [Request Permissions]

21 October 2009

Abstract original article: J. Patel, L. Melly, and M. N. Sheppard
Primary cardiac lymphoma: B- and T-cell cases at a specialist UK centre
Annals of Oncology Advance Access published on October 21, 2009.
doi:10.1093/annonc/mdp424
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: S. Sukumaran, K. B. Pittman, W. K. Patterson, J. Dickson, S. Yeend, A. Townsend, V. Broadbridge, and T. J. Price
A phase I study to determine the safety, tolerability and maximum tolerated dose of green-lipped mussel (Perna canaliculus) lipid extract, in patients with advanced prostate and breast cancer
Annals of Oncology Advance Access published on October 21, 2009.
doi:10.1093/annonc/mdp420
[Abstract] [Full Text] [PDF] [Request Permissions]

19 October 2009

Abstract original article: A. Niwinska, M. Murawska, and K. Pogoda
Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT)
Annals of Oncology Advance Access published on October 19, 2009.
doi:10.1093/annonc/mdp407
[Abstract] [Full Text] [PDF] [Request Permissions]

15 October 2009

Abstract original article: D. J. Sher, R. B. Tishler, D. Annino, and R. S. Punglia
Cost-effectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer
Annals of Oncology Advance Access published on October 15, 2009.
doi:10.1093/annonc/mdp405
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: E. Botteri, V. Bagnardi, N. Rotmensz, O. Gentilini, D. Disalvatore, B. Bazolli, A. Luini, and U. Veronesi
Analysis of local and regional recurrences in breast cancer after conservative surgery
Annals of Oncology Advance Access published on October 15, 2009.
doi:10.1093/annonc/mdp386
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: A. Zaanan, P. Cuilliere-Dartigues, A. Guilloux, Y. Parc, C. Louvet, A. de Gramont, E. Tiret, S. Dumont, B. Gayet, P. Validire, J.-F. Fléjou, A. Duval, and F. Praz
Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin
Annals of Oncology Advance Access published on October 15, 2009.
doi:10.1093/annonc/mdp383
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: J. B. Cwikla, A. Sankowski, N. Seklecka, J. R. Buscombe, A. Nasierowska-Guttmejer, K. G. Jeziorski, R. Mikolajczak, D. Pawlak, K. Stepien, and J. Walecki
Efficacy of radionuclide treatment DOTATATE Y-90 in patients with progressive metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NETs): a phase II study
Annals of Oncology Advance Access published on October 15, 2009.
doi:10.1093/annonc/mdp372
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: J. A. Treat, R. Gonin, M. A. Socinski, M. J. Edelman, R. B. Catalano, D. M. Marinucci, R. Ansari, H. H. Gillenwater, K. M. Rowland, R. L. Comis, C. K. Obasaju, C. P. Belani, and for the Alpha Oncology Research Network
A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer
Annals of Oncology Advance Access published on October 15, 2009.
doi:10.1093/annonc/mdp352
[Abstract] [Full Text] [PDF] [Request Permissions]

14 October 2009

Abstract original article: N. Kucher, D. Spirk, I. Baumgartner, L. Mazzolai, W. Korte, D. Nobel, M. Banyai, and H. Bounameaux
Lack of prophylaxis before the onset of acute venous thromboembolism among hospitalized cancer patients: the SWIss Venous ThromboEmbolism Registry (SWIVTER)
Annals of Oncology Advance Access published on October 14, 2009.
doi:10.1093/annonc/mdp406
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: H. G. Mar Fan, N. Houédé-Tchen, I. Chemerynsky, Q.-L. Yi, W. Xu, B. Harvey, and I. F. Tannock
Menopausal symptoms in women undergoing chemotherapy-induced and natural menopause: a prospective controlled study
Annals of Oncology Advance Access published on October 14, 2009.
doi:10.1093/annonc/mdp394
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: K. N. Syrigos, J. Vansteenkiste, P. Parikh, J. von Pawel, C. Manegold, R. G. Martins, L. Simms, K. P. Sugarman, C. Visseren-Grul, and G. V. Scagliotti
Prognostic and predictive factors in a randomized phase III trial comparing cisplatin–pemetrexed versus cisplatin–gemcitabine in advanced non-small-cell lung cancer
Annals of Oncology Advance Access published on October 14, 2009.
doi:10.1093/annonc/mdp392
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article
W. Koizumi, N. Boku, K. Yamaguchi, Y. Miyata, A. Sawaki, T. Kato, Y. Toh, I. Hyodo, T. Nishina, T. Furuhata, K. Miyashita, and Y. Okada
Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer
Annals of Oncology Advance Access published on October 14, 2009.
doi:10.1093/annonc/mdp371
[Abstract] [Full Text] [PDF] OPEN ACCESS ARTICLE

13 October 2009

Abstract original article: W. Kwan, A. J. Al-Tourah, C. Speers, R. Woods, H. Kennecke, and I. A. Olivotto
Does HER2 status influence locoregional failure rates in breast cancer patients treated with mastectomy for pT_1–2pN₀ disease?
Annals of Oncology Advance Access published on October 13, 2009.
doi:10.1093/annonc/mdp396
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: G. Cervetti, S. Galimberti, E. Sordi, G. Buda, E. Orciuolo, N. Cecconi, and M. Petrini
Significant efficacy of 2-CdA with or without rituximab in the treatment of splenic marginal zone lymphoma (SMZL)
Annals of Oncology Advance Access published on October 13, 2009.
doi:10.1093/annonc/mdp395
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: S. Mook, M. K. Schmidt, B. Weigelt, B. Kreike, I. Eekhout, M. J. van de Vijver, A. M. Glas, A. Floore, E. J. T. Rutgers, and L. J. van ‘t Veer
The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age
Annals of Oncology Advance Access published on October 13, 2009.
doi:10.1093/annonc/mdp388
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: A. Inoue, O. Ishimoto, S. Fukumoto, K. Usui, T. Suzuki, H. Yokouchi, M. Maemondo, M. Kanbe, S. Ogura, T. Harada, S. Oizumi, M. Harada, S. Sugawara, T. Fukuhara, and T. Nukiwa
A phase II study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0405
Annals of Oncology Advance Access published on October 13, 2009.
doi:10.1093/annonc/mdp384
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract review: A. Salem
Dismissing links between HPV and aggressive tongue cancer in young patients
Annals of Oncology Advance Access published on October 13, 2009.
doi:10.1093/annonc/mdp380
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: D. S. Boss, G. K. Schwartz, M. R. Middleton, D. D. Amakye, H. Swaisland, R. S. Midgley, M. Ranson, S. Danson, H. Calvert, R. Plummer, C. Morris, R. D. Carvajal, L. R. Chirieac, J. H. M. Schellens, and G. I. Shapiro
Safety, tolerability, pharmacokinetics and pharmacodynamics of the oral cyclin-dependent kinase inhibitor AZD5438 when administered at intermittent and continuous dosing schedules in patients with advanced solid tumours
Annals of Oncology Advance Access published on October 13, 2009.
doi:10.1093/annonc/mdp377
[Abstract] [Full Text] [PDF] [Supplementary Data] [Request Permissions]

Abstract original article: R. M'kacher, L. Andreoletti, S. Flamant, F. Milliat, T. Girinsky, J. Dossou, D. Violot, E. Assaf, B. Clausse, S. Koscielny, J. Bourhis, J. Bosq, A. Bernheim, C. Parmentier, and P. Carde
JC human polyomavirus is associated to chromosomal instability in peripheral blood lymphocytes of Hodgkin’s lymphoma patients and poor clinical outcome
Annals of Oncology Advance Access published on October 13, 2009.
doi:10.1093/annonc/mdp375
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: R. de Crevoisier, K. Slimane, T. Messai, P. Wibault, F. Eschwege, A. Bossi, S. Koscielny, A. Bridier, C. Massard, and K. Fizazi
Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy
Annals of Oncology Advance Access published on October 13, 2009.
doi:10.1093/annonc/mdp365
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: K. Hancke, M. D. Denkinger, J. König, C. Kurzeder, A. Wöckel, D. Herr, M. Blettner, and R Kreienberg
Standard treatment of female patients with breast cancer decreases substantially for women aged 70 years and older: a German clinical cohort study
Annals of Oncology Advance Access published on October 13, 2009.
doi:10.1093/annonc/mdp364
[Abstract] [Full Text] [PDF] [Request Permissions]

11 October 2009

Abstract original article: G. Goldzweig, E. Andritsch, A. Hubert, B. Brenner, N. Walach, S. Perry, and L. Baider
Psychological distress among male patients and male spouses: what do oncologists need to know?
Annals of Oncology Advance Access published on October 11, 2009.
doi:10.1093/annonc/mdp398
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: A. Lorch, A. Neubauer, M. Hackenthal, A. Dieing, J. T. Hartmann, O. Rick, C. Bokemeyer, and J. Beyer
High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors
Annals of Oncology Advance Access published on October 11, 2009.
doi:10.1093/annonc/mdp366
[Abstract] [Full Text] [PDF] [Request Permissions]

9 October 2009

Abstract original article
H. Joensuu, L. Sailas, T. Alanko, K. Sunela, R. Huuhtanen, M. Utriainen, R. Kokko, P. Bono, T. Wigren, S. Pyrhönen, T. Turpeenniemi-Hujanen, R. Asola, M. Leinonen, M. Hahka-Kemppinen, and P. Kellokumpu-Lehtinen
Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial
Annals of Oncology Advance Access published on October 9, 2009.
doi:10.1093/annonc/mdp397
[Abstract] [Full Text] [PDF] [Supplementary Data] OPEN ACCESS ARTICLE

8 October 2009

Abstract original article: G. Capri, J. Chang, S.-C. Chen, P. Conte, K. Cwiertka, G. Jerusalem, Z. Jiang, S. Johnston, B. Kaufman, J. Link, J. Ro, J. Schütte, C. Oliva, R. Parikh, A. Preston, J. Rosenlund, M. Selzer, D. Zembryki, and S. De Placido
An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer
Annals of Oncology Advance Access originally published on October 8, 2009. This version published November 2, 2009.
doi:10.1093/annonc/mdp373
[Abstract] [Full Text] [PDF] [Request Permissions]

letter to the editor: Y.-K. Kang
Reply to ‘Are we representing the true population in oncology trials?’
Annals of Oncology Advance Access published on October 8, 2009.
doi:10.1093/annonc/mdp462
[Extract] [Full Text] [PDF] [Request Permissions]

Abstract original article: B. Seruga, P. C. Hertz, L. W. Le, and I. F. Tannock
Global drug development in cancer: a cross-sectional study of clinical trial registries
Annals of Oncology Advance Access published on October 8, 2009.
doi:10.1093/annonc/mdp403
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: T. Sakakibara, A. Inoue, S. Sugawara, M. Maemondo, T. Ishida, K. Usui, T. Abe, M. Kanbe, H. Watanabe, Y. Saijo, and T. Nukiwa
Randomized phase II trial of weekly paclitaxel combined with carboplatin versus standard paclitaxel combined with carboplatin for elderly patients with advanced non-small-cell lung cancer
Annals of Oncology Advance Access published on October 8, 2009.
doi:10.1093/annonc/mdp401
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: G. Frasci, G. D'Aiuto, P. Comella, M. D'Aiuto, M. Di Bonito, P. Ruffolo, G. Iodice, A. Petrillo, S. Lastoria, P. Oliviero, I. Capasso, M. Montella, C. Siani, M. Santangelo, L. Vizioli, G. Comella, and for the Southern Italy Cooperative Oncology Group (SICOG) Italy
Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis in locally advanced breast cancer patients: an update of the Southern Italy Cooperative Oncology Group (SICOG) randomised trial 9908
Annals of Oncology Advance Access published on October 8, 2009.
doi:10.1093/annonc/mdp356
[Abstract] [Full Text] [PDF] [Request Permissions]

22 September 2009

letter to the editor: T. Pukrop, A. Bleckmann, A. Einspanier, and C. Binder
Rapid progression of hormone receptor-negative breast cancer concomitant with ovarian stimulation—a paradoxon?
Annals of Oncology Advance Access published on September 22, 2009.
doi:10.1093/annonc/mdp457
[Extract] [Full Text] [PDF] [Request Permissions]

Abstract original article: M. Li, Z.-H. Miao, Z. Chen, Q. Chen, M. Gui, L.-P. Lin, P. Sun, Y.-H. Yi, and J. Ding
Echinoside A, a new marine-derived anticancer saponin, targets topoisomerase2 ${alpha}$ by unique interference with its DNA binding and catalytic cycle
Annals of Oncology Advance Access published on September 22, 2009.
doi:10.1093/annonc/mdp335
[Abstract] [Full Text] [PDF] [Request Permissions]

21 September 2009

letter to the editor: F. Vignani, L. Russo, M. Tucci, M. Motta, G. Vellani, M. Tampellini, M. Papotti, L. Dogliotti, and A. Berruti
Why castration-resistant prostate cancer patients with neuroendocrine differentiation should be addressed to a cisplatin-based regimen
Annals of Oncology Advance Access published on September 21, 2009.
doi:10.1093/annonc/mdp456
[Extract] [Full Text] [PDF] [Request Permissions]

18 September 2009

Abstract original article
S. Siena, L. Crinò, M. Danova, S. Del Prete, S. Cascinu, S. Salvagni, I. Schiavetto, M. Vitali, and E. Bajetta
Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study
Annals of Oncology Advance Access published on September 18, 2009.
doi:10.1093/annonc/mdp343
[Abstract] [Full Text] [PDF] OPEN ACCESS ARTICLE

Abstract original article: F. Cappuzzo, G. Tallini, G. Finocchiaro, R. S. Wilson, C. Ligorio, L. Giordano, L. Toschi, M. Incarbone, R. Cavina, L. Terracciano, M. Roncalli, M. Alloisio, M. Varella-Garcia, W. A. Franklin, and A. Santoro
Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients
Annals of Oncology Advance Access published on September 18, 2009.
doi:10.1093/annonc/mdp357
[Abstract] [Full Text] [PDF] [Request Permissions]

16 September 2009

letter to the editor: S. R. Lord, P. S. Hall, and M. T. Seymour
Are we representing the true population in oncology trials?
Annals of Oncology Advance Access published on September 16, 2009.
doi:10.1093/annonc/mdp461
[Extract] [Full Text] [PDF] [Request Permissions]

Abstract original article: J. S. Lee, S.-I. Cho, and H. S. Park
Metabolic syndrome and cancer-related mortality among Korean men and women
Annals of Oncology Advance Access published on September 16, 2009.
doi:10.1093/annonc/mdp344
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: K. Prabhash, N. Khattry, A. Bakshi, R. Karandikar, A. Joshi, S. Kannan, P. S. R. K. Sastry, P. Parikh, and J. A. Kode
CD26 expression in donor stem cell harvest and its correlation with engraftment in human haematopoietic stem cell transplantation: potential predictor of early engraftment
Annals of Oncology Advance Access published on September 16, 2009.
doi:10.1093/annonc/mdp342
[Abstract] [Full Text] [PDF] [Supplementary Data] [Request Permissions]

Abstract original article: N. Methy, L. Bedenne, T. Conroy, O. Bouché, O. Chapet, M. Ducreux, J.-P. Gérard, and F. Bonnetain
Surrogate end points for overall survival and local control in neoadjuvant rectal cancer trials: statistical evaluation based on the FFCD 9203 trial
Annals of Oncology Advance Access published on September 16, 2009.
doi:10.1093/annonc/mdp340
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: J. G. Kim, Y. S. Chae, S. K. Sohn, J. H. Moon, B. W. Kang, J. Y. Park, S. W. Jeon, M.-H. Lee, K.-H. Lim, G. S. Choi, and S.-H. Jun
IVS10+12A>G polymorphism in hMSH2 gene associated with prognosis for patients with colorectal cancer
Annals of Oncology Advance Access published on September 16, 2009.
doi:10.1093/annonc/mdp338
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: S. M. Edwards-Bennett, L. M. Jacks, C. H. Moskowitz, E. J. Wu, Z. Zhang, A. Noy, C. S. Portlock, D. J. Straus, A. D. Zelenetz, and J. Yahalom
Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience
Annals of Oncology Advance Access published on September 16, 2009.
doi:10.1093/annonc/mdp337
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: L. Righi, M. Volante, V. Tavaglione, A. Billè, L. Daniele, T. Angusti, F. Inzani, G. Pelosi, G. Rindi, and M. Papotti
Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 ‘clinically aggressive’ cases
Annals of Oncology Advance Access published on September 16, 2009.
doi:10.1093/annonc/mdp334
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: D. Wu, L. Chen, W. Liao, Y. Ding, Q. Zhang, Z. Li, and L. Liu
Fascin1 expression predicts poor prognosis in patients with nasopharyngeal carcinoma and correlates with tumor invasion
Annals of Oncology Advance Access published on September 16, 2009.
doi:10.1093/annonc/mdp333
[Abstract] [Full Text] [PDF] [Request Permissions]

13 September 2009

letter to the editor: U. Sahin, A. Alkan, and K. Altundag
Bone morphogenetic proteins and zoledronic acid
Annals of Oncology Advance Access published on September 13, 2009.
doi:10.1093/annonc/mdp429
[Extract] [Full Text] [PDF] [Request Permissions]

28 August 2009

Abstract review: A. G. Pallis, C. Gridelli, J. P. van Meerbeeck, L. Greillier, U. Wedding, D. Lacombe, J. Welch, C. P. Belani, and M. Aapro
EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts’ opinion for the treatment of non-small-cell lung cancer in an elderly population
Annals of Oncology Advance Access published on August 28, 2009.
doi:10.1093/annonc/mdp360
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article
G. Bertelli, E. Hall, E. Ireland, C. F. Snowdon, J. Jassem, K. Drosik, H. Karnicka-Mlodkowska, R. C. Coombes, and J. M. Bliss
Long-term endometrial effects in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES)—a randomised controlled trial of exemestane versus continued tamoxifen after 2–3 years tamoxifen
Annals of Oncology Advance Access published on August 28, 2009.
doi:10.1093/annonc/mdp358
[Abstract] [Full Text] [PDF] OPEN ACCESS ARTICLE

Abstract review: T. Pienkowski and C. C. Zielinski
Trastuzumab treatment in patients with breast cancer and metastatic CNS disease
Annals of Oncology Advance Access published on August 28, 2009.
doi:10.1093/annonc/mdp353
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: E. D. Saad, A. Mangabeira, A. L. Masson, and F. E. Prisco
The geography of clinical cancer research: analysis of abstracts presented at the American Society of Clinical Oncology Annual Meetings
Annals of Oncology Advance Access published on August 28, 2009.
doi:10.1093/annonc/mdp350
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: S. Rodenhuis, I. A. M. Mandjes, J. Wesseling, M. J. van de Vijver, M.-J. T. D. F. Vrancken Peeters, G. S. Sonke, and S. C. Linn
A simple system for grading the response of breast cancer to neoadjuvant chemotherapy
Annals of Oncology Advance Access published on August 28, 2009.
doi:10.1093/annonc/mdp348
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: Y. Nadler, A. M. González, R. L. Camp, D. L. Rimm, H. M. Kluger, and Y. Kluger
Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer
Annals of Oncology Advance Access published on August 28, 2009.
doi:10.1093/annonc/mdp346
[Abstract] [Full Text] [PDF] [Supplementary Data] [Request Permissions]

27 August 2009

Abstract review: R. P. Riechelmann and A. Del Giglio
Drug interactions in oncology: how common are they?
Annals of Oncology Advance Access published on August 27, 2009.
doi:10.1093/annonc/mdp369
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: G. Rosati, S. Cordio, R. Bordonaro, G. Caputo, G. Novello, G. Reggiardo, and L. Manzione
Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomized phase II study
Annals of Oncology Advance Access published on August 27, 2009.
doi:10.1093/annonc/mdp359
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: K. J. Ruddy, S. Gelber, J. Shin, J. E. Garber, R. Rosenberg, M. Przypysny, and A. H. Partridge
Genetic testing in young women with breast cancer: results from a Web-based survey
Annals of Oncology Advance Access published on August 27, 2009.
doi:10.1093/annonc/mdp355
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract original article: M. Mandalà, S. Barni, M. Prins, R. Labianca, C. Tondini, L. Russo, A. Milesi, M. Cremonesi, M. Zaccanelli, C. Regonesi, C. Moro, and A. Falanga
Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial
Annals of Oncology Advance Access published on August 27, 2009.
doi:10.1093/annonc/mdp354
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract review: B. Markman, F. Atzori, J. Pérez-García, J. Tabernero, and J. Baselga
Status of PI3K inhibition and biomarker development in cancer therapeutics
Annals of Oncology Advance Access published on August 27, 2009.
doi:10.1093/annonc/mdp347
[Abstract] [Full Text] [PDF] [Request Permissions]

24 August 2009

Abstract original article: C. Bouchardy, E. Rapiti, M. Usel, S. Balmer Majno, G. Vlastos, S. Benhamou, R. Miralbell, I. Neyroud-Caspar, H. M. Verkooijen, and V. Vinh-Hung
Excess of cardiovascular mortality among node-negative breast cancer patients irradiated for inner-quadrant tumors
Annals of Oncology Advance Access published on August 24, 2009.
doi:10.1093/annonc/mdp341
[Abstract] [Full Text] [PDF] [Request Permissions]

18 August 2009

Abstract original article: E. P. M. Jansen, H. Boot, R. Dubbelman, M. Verheij, and A. Cats
Postoperative chemoradiotherapy in gastric cancer––a phase I–II study of radiotherapy with dose escalation of weekly cisplatin and daily capecitabine chemotherapy
Annals of Oncology Advance Access published on August 18, 2009.
doi:10.1093/annonc/mdp345
[Abstract] [Full Text] [PDF] [Request Permissions]

Abstract review: M. J. Duffy, C. Sturgeon, R. Lamerz, C. Haglund, V. L. Holubec, R. Klapdor, A. Nicolini, O. Topolcan, and V. Heinemann
Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report
Annals of Oncology Advance Access originally published on August 18, 2009. This version published September 8, 2009.
doi:10.1093/annonc/mdp332
[Abstract] [Full Text] [PDF] [Request Permissions]

14 August 2009

Abstract original article: W. S. Owadally, M. R. Sydes, J. A. Radford, B. W. Hancock, M. H. Cullen, S. P. Stenning, and P. W. M. Johnson
Initial dose intensity has limited impact on the outcome of ABVD chemotherapy for advanced Hodgkin lymphoma (HL): data from UKLG LY09 (ISRCTN97144519)
Annals of Oncology Advance Access published on August 14, 2009.
doi:10.1093/annonc/mdp331
[Abstract] [Full Text] [PDF] [Request Permissions]